The application P38 inhibitor reduces the AKT expression in colon cancer cell line

ZHANG Jun,LI Jinpeng,YU Honggang
DOI: https://doi.org/10.3969/j.issn.1006-5709.2012.11.008
2012-01-01
Abstract:Objective To evaluate the sensitive effect and the possible mechanisms of chemoresisitance of SB203580,a p38MAPK inhibitor,on colon cancer cell line HCT-116 when combined with cisplatin.Methods Colon cancer cells HCT-116 were used as experimental subjects.The concentration of SB203580 was setted to 20 mg/L,the concentration of cisplatin was 100 μmol/L.After treatment,MTT was used to measure inhibitory effects,flow cytometry was used to investigate the apoptosis of HCT-116 and AKT was detected by RT-PCR.Results After combined group of SB203580 and cisplatin,the growth inhibition rate of HCT-116 cells was significantly increased compared with cisplatin group and SB203580 group.The apoptotic rate was also significantly increased when cisplatin combined with SB203580.The AKT expression was significantly higher in the cisplatin group than in combination group.Conclusion SB203580 could reduced the AKT expression and sensitized cisplatin on its lethal effect of HCT-116 cells.
What problem does this paper attempt to address?